Annual Net Income
-$69.05 M
-$32.13 M-87.03%
31 December 2023
Summary:
Armata Pharmaceuticals annual net profit is currently -$69.05 million, with the most recent change of -$32.13 million (-87.03%) on 31 December 2023. During the last 3 years, it has fallen by -$46.86 million (-211.28%). ARMP annual net income is now -398.78% below its all-time high of $23.11 million, reached on 31 December 2014.ARMP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$5.48 M
-$14.47 M-160.99%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly net profit is currently -$5.48 million, with the most recent change of -$14.47 million (-160.99%) on 30 September 2024. Over the past year, it has increased by +$25.68 million (+82.41%). ARMP quarterly net income is now -125.85% below its all-time high of $21.21 million, reached on 30 September 2014.ARMP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$41.36 M
+$25.68 M+38.30%
30 September 2024
Summary:
Armata Pharmaceuticals TTM net profit is currently -$41.36 million, with the most recent change of +$25.68 million (+38.30%) on 30 September 2024. Over the past year, it has increased by +$18.15 million (+30.50%). ARMP TTM net income is now -270.70% below its all-time high of $24.23 million, reached on 30 September 2014.ARMP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.0% | +82.4% | +30.5% |
| 3 y3 years | -211.3% | -1.1% | -74.3% |
| 5 y5 years | -470.1% | +21.2% | -262.8% |
ARMP Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -211.3% | at low | -161.0% | +82.4% | -78.6% | +48.0% |
| 5 y | 5 years | -470.1% | at low | -161.0% | +82.4% | -262.8% | +48.0% |
| alltime | all time | -398.8% | at low | -125.8% | +88.8% | -270.7% | +48.0% |
Armata Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.48 M(-161.0%) | -$41.36 M(-38.3%) |
| June 2024 | - | $8.99 M(-135.9%) | -$67.04 M(-15.7%) |
| Mar 2024 | - | -$25.02 M(+26.1%) | -$79.58 M(+15.3%) |
| Dec 2023 | -$69.05 M(+87.0%) | -$19.85 M(-36.3%) | -$69.05 M(+16.0%) |
| Sept 2023 | - | -$31.16 M(+778.5%) | -$59.51 M(+61.0%) |
| June 2023 | - | -$3.55 M(-75.5%) | -$36.97 M(-13.3%) |
| Mar 2023 | - | -$14.49 M(+40.5%) | -$42.63 M(+15.5%) |
| Dec 2022 | -$36.92 M(+59.4%) | -$10.31 M(+19.7%) | -$36.92 M(+13.1%) |
| Sept 2022 | - | -$8.61 M(-6.5%) | -$32.65 M(+10.8%) |
| June 2022 | - | -$9.21 M(+5.0%) | -$29.45 M(+11.4%) |
| Mar 2022 | - | -$8.77 M(+45.1%) | -$26.43 M(+14.2%) |
| Dec 2021 | -$23.16 M(+4.4%) | -$6.05 M(+11.6%) | -$23.16 M(-2.4%) |
| Sept 2021 | - | -$5.42 M(-12.5%) | -$23.73 M(-1.5%) |
| June 2021 | - | -$6.19 M(+12.7%) | -$24.08 M(+6.6%) |
| Mar 2021 | - | -$5.50 M(-17.0%) | -$22.60 M(+1.9%) |
| Dec 2020 | -$22.18 M(+13.9%) | -$6.62 M(+14.8%) | -$22.18 M(+10.1%) |
| Sept 2020 | - | -$5.77 M(+22.5%) | -$20.14 M(-5.6%) |
| June 2020 | - | -$4.71 M(-7.2%) | -$21.33 M(+2.5%) |
| Mar 2020 | - | -$5.08 M(+10.7%) | -$20.82 M(+6.9%) |
| Dec 2019 | -$19.48 M(+60.9%) | -$4.59 M(-34.1%) | -$19.48 M(+70.8%) |
| Sept 2019 | - | -$6.96 M(+65.6%) | -$11.40 M(+58.0%) |
| June 2019 | - | -$4.20 M(+12.3%) | -$7.22 M(+18.9%) |
| Mar 2019 | - | -$3.74 M(-207.1%) | -$6.07 M(+11.1%) |
| Dec 2018 | -$12.11 M(-5.7%) | $3.49 M(-226.0%) | -$5.46 M(-51.7%) |
| Sept 2018 | - | -$2.77 M(-9.1%) | -$11.31 M(+21.4%) |
| June 2018 | - | -$3.05 M(-2.7%) | -$9.31 M(-26.8%) |
| Mar 2018 | - | -$3.13 M(+33.2%) | -$12.73 M(-0.9%) |
| Dec 2017 | -$12.84 M(-31.9%) | -$2.35 M(+201.9%) | -$12.84 M(-35.8%) |
| Sept 2017 | - | -$779.00 K(-87.9%) | -$19.99 M(-7.4%) |
| June 2017 | - | -$6.46 M(+99.0%) | -$21.58 M(+13.8%) |
| Mar 2017 | - | -$3.25 M(-65.8%) | -$18.97 M(+0.7%) |
| Dec 2016 | -$18.84 M(+3550.8%) | -$9.50 M(+300.0%) | -$18.84 M(+62.8%) |
| Sept 2016 | - | -$2.38 M(-38.3%) | -$11.57 M(+208.1%) |
| June 2016 | - | -$3.85 M(+23.7%) | -$3.75 M(-134.6%) |
| Mar 2016 | - | -$3.11 M(+39.5%) | $10.87 M(-2205.6%) |
| Dec 2015 | -$516.00 K(-102.2%) | -$2.23 M(-141.0%) | -$516.00 K(-149.1%) |
| Sept 2015 | - | $5.44 M(-49.5%) | $1.05 M(-93.8%) |
| June 2015 | - | $10.77 M(-174.3%) | $16.82 M(-15.6%) |
| Mar 2015 | - | -$14.49 M(+2082.7%) | $19.92 M(-13.8%) |
| Dec 2014 | $23.11 M(-135.8%) | -$664.00 K(-103.1%) | $23.11 M(-4.6%) |
| Sept 2014 | - | $21.21 M(+52.9%) | $24.23 M(-153.0%) |
| June 2014 | - | $13.87 M(-222.7%) | -$45.73 M(-38.4%) |
| Mar 2014 | - | -$11.31 M(-2568.8%) | -$74.25 M(+15.0%) |
| Dec 2013 | -$64.58 M(+5718.3%) | $458.00 K(-100.9%) | -$64.58 M(-0.7%) |
| Sept 2013 | - | -$48.75 M(+232.9%) | -$65.04 M(+299.3%) |
| June 2013 | - | -$14.64 M(+790.2%) | -$16.29 M(+890.2%) |
| Mar 2013 | - | -$1.65 M(-345.2%) | -$1.65 M(-64.6%) |
| Dec 2012 | -$1.11 M(-94.6%) | - | - |
| Sept 2009 | - | $671.00 K(-90.8%) | -$4.65 M(-41.7%) |
| June 2009 | - | $7.31 M(-509.8%) | -$7.98 M(-58.2%) |
| Mar 2009 | - | -$1.78 M(-83.6%) | -$19.09 M(-7.9%) |
| Dec 2008 | -$20.72 M(+28.5%) | -$10.85 M(+307.7%) | -$20.72 M(+38.7%) |
| Sept 2008 | - | -$2.66 M(-29.9%) | -$14.94 M(-2.4%) |
| June 2008 | - | -$3.80 M(+11.3%) | -$15.31 M(-2.5%) |
| Mar 2008 | - | -$3.41 M(-32.7%) | -$15.70 M(-2.6%) |
| Dec 2007 | -$16.13 M | -$5.07 M(+67.4%) | -$16.13 M(+57.4%) |
| Sept 2007 | - | -$3.03 M(-27.6%) | -$10.25 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$4.19 M(+9.2%) | -$10.40 M(-69.5%) |
| Mar 2007 | - | -$3.84 M(-574.8%) | -$34.09 M(+0.3%) |
| Dec 2006 | -$33.99 M(+77.0%) | $808.00 K(-125.3%) | -$33.99 M(-11.4%) |
| Sept 2006 | - | -$3.19 M(-88.6%) | -$38.35 M(-6.1%) |
| June 2006 | - | -$27.88 M(+646.9%) | -$40.84 M(+123.7%) |
| Mar 2006 | - | -$3.73 M(+5.2%) | -$18.26 M(-4.9%) |
| Dec 2005 | -$19.20 M(+34.7%) | -$3.55 M(-37.6%) | -$19.20 M(+7.4%) |
| Sept 2005 | - | -$5.68 M(+7.3%) | -$17.87 M(+19.8%) |
| June 2005 | - | -$5.29 M(+13.3%) | -$14.91 M(+6.0%) |
| Mar 2005 | - | -$4.67 M(+110.0%) | -$14.07 M(-1.3%) |
| Dec 2004 | -$14.26 M(-3.9%) | -$2.23 M(-18.3%) | -$14.26 M(-22.3%) |
| Sept 2004 | - | -$2.72 M(-38.8%) | -$18.34 M(+11.9%) |
| June 2004 | - | -$4.45 M(-8.4%) | -$16.40 M(-13.1%) |
| Mar 2004 | - | -$4.86 M(-23.0%) | -$18.86 M(+27.2%) |
| Dec 2003 | -$14.83 M(-37.6%) | -$6.31 M(+708.7%) | -$14.83 M(+1.5%) |
| Sept 2003 | - | -$780.00 K(-88.7%) | -$14.62 M(-21.7%) |
| June 2003 | - | -$6.92 M(+733.1%) | -$18.67 M(+2.6%) |
| Mar 2003 | - | -$830.00 K(-86.4%) | -$18.19 M(-23.5%) |
| Dec 2002 | -$23.77 M(-12.5%) | -$6.09 M(+26.0%) | -$23.77 M(-7.7%) |
| Sept 2002 | - | -$4.83 M(-24.9%) | -$25.75 M(-7.7%) |
| June 2002 | - | -$6.44 M(+0.5%) | -$27.91 M(+2.1%) |
| Mar 2002 | - | -$6.41 M(-20.6%) | -$27.33 M(+0.6%) |
| Dec 2001 | -$27.17 M(-43.0%) | -$8.07 M(+15.4%) | -$27.17 M(-15.2%) |
| Sept 2001 | - | -$6.99 M(+19.2%) | -$32.03 M(-39.1%) |
| June 2001 | - | -$5.86 M(-6.1%) | -$52.62 M(+3.5%) |
| Mar 2001 | - | -$6.24 M(-51.7%) | -$50.84 M(+6.7%) |
| Dec 2000 | -$47.66 M(+78.5%) | -$12.93 M(-53.1%) | -$47.66 M(+26.7%) |
| Sept 2000 | - | -$27.58 M(+575.0%) | -$37.62 M(+49.0%) |
| June 2000 | - | -$4.09 M(+33.4%) | -$25.25 M(-6.7%) |
| Mar 2000 | - | -$3.06 M(+5.6%) | -$27.06 M(+1.4%) |
| Dec 1999 | -$26.70 M(+206.9%) | -$2.90 M(-80.9%) | -$26.70 M(+20.3%) |
| Sept 1999 | - | -$15.20 M(+157.6%) | -$22.20 M(+113.5%) |
| June 1999 | - | -$5.90 M(+118.5%) | -$10.40 M(+35.1%) |
| Mar 1999 | - | -$2.70 M(-268.8%) | -$7.70 M(-12.5%) |
| Dec 1998 | -$8.70 M(-38.7%) | $1.60 M(-147.1%) | -$8.80 M(-39.7%) |
| Sept 1998 | - | -$3.40 M(+6.3%) | -$14.60 M(+4.3%) |
| June 1998 | - | -$3.20 M(-15.8%) | -$14.00 M(-4.1%) |
| Mar 1998 | - | -$3.80 M(-9.5%) | -$14.60 M(+2.1%) |
| Dec 1997 | -$14.20 M(-45.4%) | -$4.20 M(+50.0%) | -$14.30 M(+7.5%) |
| Sept 1997 | - | -$2.80 M(-26.3%) | -$13.30 M(-5.0%) |
| June 1997 | - | -$3.80 M(+8.6%) | -$14.00 M(-47.4%) |
| Mar 1997 | - | -$3.50 M(+9.4%) | -$26.60 M(+2.3%) |
| Dec 1996 | -$26.00 M(+162.6%) | -$3.20 M(-8.6%) | -$26.00 M(+2.0%) |
| Sept 1996 | - | -$3.50 M(-78.7%) | -$25.50 M(+5.4%) |
| June 1996 | - | -$16.40 M(+465.5%) | -$24.20 M(+137.3%) |
| Mar 1996 | - | -$2.90 M(+7.4%) | -$10.20 M(+3.0%) |
| Dec 1995 | -$9.90 M(+17.9%) | -$2.70 M(+22.7%) | -$9.90 M(+4.2%) |
| Sept 1995 | - | -$2.20 M(-8.3%) | -$9.50 M(0.0%) |
| June 1995 | - | -$2.40 M(-7.7%) | -$9.50 M(+3.3%) |
| Mar 1995 | - | -$2.60 M(+13.0%) | -$9.20 M(+9.5%) |
| Dec 1994 | -$8.40 M(+64.7%) | -$2.30 M(+4.5%) | -$8.40 M(+13.5%) |
| Sept 1994 | - | -$2.20 M(+4.8%) | -$7.40 M(+13.8%) |
| June 1994 | - | -$2.10 M(+16.7%) | -$6.50 M(+14.0%) |
| Mar 1994 | - | -$1.80 M(+38.5%) | -$5.70 M(+11.8%) |
| Dec 1993 | -$5.10 M | -$1.30 M(0.0%) | -$5.10 M(+34.2%) |
| Sept 1993 | - | -$1.30 M(0.0%) | -$3.80 M(+52.0%) |
| June 1993 | - | -$1.30 M(+8.3%) | -$2.50 M(+108.3%) |
| Mar 1993 | - | -$1.20 M | -$1.20 M |
FAQ
- What is Armata Pharmaceuticals annual net profit?
- What is the all time high annual net income for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual net income year-on-year change?
- What is Armata Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly net income year-on-year change?
- What is Armata Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals TTM net income year-on-year change?
What is Armata Pharmaceuticals annual net profit?
The current annual net income of ARMP is -$69.05 M
What is the all time high annual net income for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual net profit is $23.11 M
What is Armata Pharmaceuticals annual net income year-on-year change?
Over the past year, ARMP annual net profit has changed by -$32.13 M (-87.03%)
What is Armata Pharmaceuticals quarterly net profit?
The current quarterly net income of ARMP is -$5.48 M
What is the all time high quarterly net income for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly net profit is $21.21 M
What is Armata Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ARMP quarterly net profit has changed by +$25.68 M (+82.41%)
What is Armata Pharmaceuticals TTM net profit?
The current TTM net income of ARMP is -$41.36 M
What is the all time high TTM net income for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high TTM net profit is $24.23 M
What is Armata Pharmaceuticals TTM net income year-on-year change?
Over the past year, ARMP TTM net profit has changed by +$18.15 M (+30.50%)